PureTech Health (LON:PRTC) Stock Price Up 14.2% – Here’s Why

Shares of PureTech Health plc (LON:PRTC) rose 14.2% on Saturday . The stock traded as high as GBX 123.80 ($1.67) and last traded at GBX 121.50 ($1.64). Approximately 9,013,305 shares were traded during trading, an increase of 1,053% from the average daily volume of 781,543 shares. The stock had previously closed at GBX 106.40 ($1.43).

PureTech Health Trading Up 14.2%

The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68. The firm has a market cap of £293.65 million, a price-to-earnings ratio of 714.71 and a beta of 1.02. The business has a fifty day simple moving average of GBX 129.46 and a 200-day simple moving average of GBX 129.72.

Insider Buying and Selling at PureTech Health

In related news, insider Bharatt Chowrira purchased 167,739 shares of the firm’s stock in a transaction dated Thursday, July 3rd. The stock was bought at an average price of GBX 1 per share, with a total value of £1,677.39. Insiders own 13.13% of the company’s stock.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.